Date: March 1, 2013
Prized Research: More than 20 years ago, Bert Vogelstein redefined the field of cancer research by discovering one and then a series of genetic mistakes responsible for colon cancer.
Today, Vogelstein is an acclaimed leader in cancer research and continues to lead his lab and others around the world in developing genetic tests, diagnostics and therapies for cancer.
In recognition of his groundbreaking work, Vogelstein, co-director of the Ludwig Center at Johns Hopkins and a Howard Hughes Medical Institute investigator, was recently awarded a Breakthrough Prize in Life Sciences.
Vogelstein was among 11 inaugural winners who will receive $3 million each for their research.
“This is a tremendous honor—an honor I share with my fellow investigators who have worked with me so tirelessly over the last three decades to pinpoint molecular genetic causes of cancer,” said Vogelstein, the Clayton Professor of Oncology at the Johns Hopkins Kimmel Cancer Center. Vogelstein first became interested in cancer research during his training at The Johns Hopkins Hospital as he observed young children suffering from leukemia.